Sort
17,288 grants matching “multiple sclerosis”
Glial Cell Regulation of Circadian Behavior
$353,719F. Rob Jackson · Tufts University Boston · R01 · FY2012 · NS
Glial Cell Regulation of Circadian Behavior
$353,719F. Rob Jackson · Tufts University Boston · R01 · FY2011 · NS
Inhibition of Antigen Presentation in Multiple Sclerosis
$353,597Dana-Farber Cancer Institute · R01 · FY2004 · NS
Clinical Core
$353,569R John Looney · University Of Rochester · P01 · FY2011 · AI
Type I Interferon-Regulated T Helper Development
$353,523John David Farrar · Ut Southwestern Medical Center · R01 · FY2012 · AI
Balance of Thymic Negative Selection vs. Treg Cell Generation in the Elderly
$353,500Dong-Ming Su · University Of North Texas Hlth Sci Ctr · R01 · FY2016 · AI
Reach, Grasp, and Manipulation
$353,430Marc H Schieber · University Of Rochester · R01 · FY2012 · NS
Vitamin D, cigarette smoking, EBV infection and risk of MS progression
$353,281Alberto Ascherio · Harvard School Of Public Health · R01 · FY2010 · NS
B cells alter adaptive autoimmunity to protect from ischemic injury after stroke
$353,281Ann Marie Stowe · Ut Southwestern Medical Center · R01 · FY2015 · NS
Role of FOXO4 in atherosclerosis
$353,250Zhi-Ping Liu · Ut Southwestern Medical Center · R01 · FY2006 · HL
Non-Canonical NF-kappaB Signaling In Endothelial Cells
$353,250Michael J May · University Of Pennsylvania · R01 · FY2006 · HL
Deficiency of SHP-1 expression and function in multiple sclerosis
$353,250Paul T Massa · Upstate Medical University · R01 · FY2009 · NS
Deficiency of SHP-1 expression and function in multiple sclerosis
$353,250Paul T Massa · Upstate Medical University · R01 · FY2010 · NS
Inhibition of Antigen Presentation in Multiple Sclerosis
$353,241Dana-Farber Cancer Institute · R01 · FY2005 · NS
Mapping the Genotype, Phenotype, and Natural History of Phelan McDermid Syndrome
$353,114Alexander Kolevzon · Boston Children'S Hospital · U54 · FY2021 · NS
RAP as a novel therapeutic to promote remyelination after MS demyelinating event
$353,106Travis Lee Stiles · Novoron Bioscience, Inc. · R43 · FY2015 · NS
T cell response to myelin proteolipid protein
$353,090Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2012 · NS
NOVO-118 as a therapeutic to promote remyelination in in vivo models of MS
$353,084Travis Lee Stiles · Novoron Bioscience, Inc. · R41 · FY2019 · NS
Interplay Between Pathogenic and Regulatory T Cells in EAE
$353,077Estelle Bettelli · Benaroya Research Inst At Virginia Mason · R01 · FY2012 · NS
Interplay Between Pathogenic and Regulatory T Cells in EAE
$353,077Estelle Bettelli · Benaroya Research Inst At Virginia Mason · R01 · FY2011 · NS
T cell response to myelin proteolipid protein
$353,038Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2011 · NS
Heterogeneity of Adult Neural Stem Cells
$352,893Arturo Alvarez-Buylla · University Of California, San Francisco · R37 · FY2009 · HD
Molecular Neuropathology
$352,800Cedric S Raine · Albert Einstein College Of Medicine · T32 · FY2006 · NS
Lipid Mediators in Corneal Nerve Regeneration
$352,800Haydee E.p. Bazan · Lsu Health Sciences Center · R01 · FY2015 · EY
Lipid Mediators in Corneal Nerve Regeneration
$352,800Haydee E.p. Bazan · Lsu Health Sciences Center · R01 · FY2014 · EY